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a b s t r a c t
Salivary a-amylase, a major protein in saliva, has been described as a marker for sympa-
thetic nervous system activity, hence for metabolic energy balance. In this context, its
expression in overweight and obesity is of interest. Rats fed with a diet enriched with
sunflower oil differentially gained weight yielding two subgroups according to their sus-
ceptibility (OP) or resistance (OR) to obesity. Elevated plasmatic levels of leptin in the OP
subgroup and altered plasmatic lipid profiles (lower triglycerides and higher total choles-
terol/HDL ratio compared to controls) in OR subgroup were observed. Animals from OP
subgroup presented higher a-amylase expression and activity even prior to the dietary
treatment, suggesting that this salivary protein may constitute a putative indicator of
susceptibility for fat tissue accumulation. After 18 weeks of high-fat diet consumption,
salivary a-amylase levels did not significantly changed in OP subgroup, but increased 3-fold
in OR subgroup. The raise of a-amylase for the latter might represent an adaptation to lower
starch intake. These results suggest that salivary a-amylase secretion might be useful to
predict susceptibility for weight gain induced by high-fat diet consumption.
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During the past decades, obesity prevalence has enormously
increased worldwide, reaching epidemic proportions in
Europe.1 An imbalance between energy intake and output,
many times involving the consumption of high amounts of fat,
is the main reason.
Sunflower oil is one of the most consumed liquid fats
worldwide, mainly used for frying foods and in salads, being
preferred by many people for its neutral taste.2 Sunflower oil is
rich in unsaturated fatty acids, such as linoleic acid (n-6 PUFA)
and oleic acid (n-3-PUFA).3 Despite some controversy, oils with
high contents of unsaturated fatty acids may induce weight
gain without most of the deleterious effects associated with
saturated fat. Some studies reported that diets rich in n-6
PUFA decrease plasmatic levels of triacylglycerol and total
cholesterol, as well as liver fat, improving metabolic status,4
insulin sensitivity5,6 and cardiovascular function,7 compara-
tively to saturated fatty acids.
Saliva has a variety of proteins with important roles in oral
health and food perception, some of which have been
suggested to influence ingestive behaviour.8,9 The interest in
the study of this fluid increased in the last decade due to
methodological developments, which revealed its potential as
a source of biomarkers of pathological and physiological
conditions, helping in the understanding of biological mecha-
nisms.10 Nonetheless, relatively few studies were found about
salivary protein composition in obesity.11
The levels of salivary a-amylase, a protein present in
considerable amounts in mixed saliva and responsible for the
hydrolysis of starch, are generally referred as a marker of
stress and an indicator of sympathetic nervous system
activity,12 which in turn plays an essential role in metabolic
homeostasis. Several studies have found elevated levels of this
salivary protein concomitant to overall changes in norepi-
nephrine in response to stress.13 Automomic nervous system
influences the regulation of salivary secretion, with sympa-
thetic nervous system activation decreasing salivary flow and
increasing salivary protein output. The stimulation of beta-
adrenergic receptors from salivary parotid glands increases
alpha-amylase secretion.14
The relation between obesity and sympathetic nervous
system activity has been somehow controversial. Low activity
of this branch of the autonomic nervous system has been
suggested to be a risk factor for weight gain and obesity
development.15 However, some evidences point that the
sympathetic neural transmitter neuropeptide Y (NPY) is
involved in stress-induced augmentation of diet-induced
obesity.16 From our knowledge it has not been addressed
whether the expression and enzymatic activity of salivary
alpha-amylase differs in obesity.
Similarly to humans, in some rodent strains there are
subjects prone and subjects resistant to obesity induced by
high-fat diet consumption.17 Although the factors underlying
this different propensity are yet poorly understood, these
animals constitute a good model to study obesity. This study
had three main objectives: to investigate how salivary alpha-
amylase levels relate to rats susceptibility for weight gain; to
evaluate the effects of the consumption of a high-fat diet insalivary alpha-amylase secretion; and to assess the indivi-
dual’s responses to high-fat diet, by evaluating biochemical
markers of metabolic status.
2. Materials and methods
2.1. Treatment of animals
Twenty outbred female Wistar rats 4 weeks old (160–223 g)
were maintained on a 12 h/12 h light/dark cycle at a constant
temperature (22 8C) and humidity (65%) with ad libitum access
to food and water. The animals were single caged in standard
rat cages and maintained on a standard diet (SAFE A04) for 4
weeks acclimation. After that time animals were randomly
divided in two dietary groups (control N = 6 and sunflower oil
treated N = 14), with the control group receiving the same
standard diet of the pre-trial period and the treatment group
receiving a high fat diet rich in sunflower oil during 18 weeks,
both ad libitum.
The experimental high-fat diet was prepared by soaking
the standard feed in sunflower oil during 4 days, followed by
drying in an oven (temperature below 40 8C) and then stored,
protected from light and oxygen. Sunflower oil used to prepare
the high-fat diet was obtained from a commercial trademark
available for human consumption. Fatty acid composition was
measured by gas chromatography (Supplementary Table S1).
Analyses of the macronutrient content of the used rodent
diets were performed in the Laboratory of Animal Nutrition of
the ICAAM, University of E´vora: sunflower oil enriched diet
containing 14.5% total protein, 48.2% carbohydrates, 14.7%
total fat, with an energetic content of 3.8 kcal/g and standard
diet containing 17.4% total protein, 53.7% carbohydrates, 2.7%
total fat, with an energetic content of 3.1 kcal/g.
Supplementary material related to this article can be
found, in the online version, at http://dx.doi.org/10.1016/j.
archoralbio.2015.02.015.
During both the acclimation and experimental periods the
animals were weighed weekly and food consumption moni-
tored, by weighing the amount distributed and the refusals. At
the end of the experiment the animals were euthanized by
exsanguination under anaesthesia and blood collected for
further analysis. All animal procedures were approved by the
scientific committee, and were supervised by a scientist
trained by the Federation of European Laboratory Animal
Science Associations (FELASA), and conformed to Portuguese
law,18 which followed European Union Laboratory Animal
Experimentation Regulations.
2.2. Oral glucose tolerance test
Oral glucose tolerance test (OGTT) was performed at the
beginning, in the middle and at the end of dietary
treatment. After overnight (16-h) fasting, blood samples were
collected from the tail vein followed by oral adminis-
tration of glucose (75 g/kg of body weight). Blood glycaemia
was measured in fast and after 30, 60, 90 and 120 min after
glucose bolus administration, using a hand-held glucometer
(Accu-Check, Roche). Whole blood glucose levels were
expressed in mg/dl.
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Blood obtained by heart puncture, after 18 weeks experiment,
was collected in EDTA coated tubes and centrifuged at
3000 rpm and room temperature for 15 min.
Plasma concentrations of insulin and leptin were measured
by enzyme-linked immunosorbent assay (ELISA). For insulin a
competitive ELISA was used [Mouse anti-rat insulin serum
(ref. BT53-3033-39 Linco Research, USA) and rat-insulin
standards (ref. 813K, Linco, Research, USA)] whereas leptin
determination was performed using a commercial kit accord-
ing to the manufacturer’s instructions (EZRL-83K Millipore).
Plasma concentrations of total and HDL cholesterol, as well as
triglycerides were measured using enzymatic tests (Sentinel
Diagnostics, Milano, Italy). Precision and reproducibility of
measurements were monitored by using a multi-parameter
control for quantitative clinical chemistry determinations
(Clin Chem Control 1, and Clin Chem Control 2, Sentinel
Diagnostics, Milan, Italy).
2.4. Saliva sample collection and protein quantification
Whole mouth saliva was collected from each individual
animal under parasympathetic stimulation, to increase flow,
facilitating saliva collection. Animals were injected with
pilocarpine (7 mg/kg body weight s.c.) and saliva aspirated
from the mouth using a micropipette and collected to a tube
maintained on ice. Although pilocarpine administration can
lead to small increases in amylase activity, the dose used was
the same for all the animals, to assure that any change in
protein levels would only reflect experimental treatment.
Collections were performed on each individual in two
different days before the beginning of the dietary treatment
and at the end of the 18 weeks experimental period. The two
individual different collections from the beginning were
pooled. After saliva collection, samples were centrifuged at
13,000  g, for 5 min to remove food and cell debris, superna-
tant aliquoted and stored at 80 8C until analysis. Bradford
method (BioRad Protein Assay) was used for total protein
quantification.
2.5. Western blot
For Western blot, SDS PAGE separation of 3 mg protein from
each sample was performed using 12% gels run at a constant
voltage of 100 V. The separated proteins were transferred to a
PDVF membrane by electroblotting using a Tris-glycine buffer
system, and the protein patterns were visualized by staining
with Ponceau S dye (0.3% w/v in 10% acetic acid) for 10 min.
The protein profiles were developed by washing away excess
dye with distilled water. For Western blot the membrane was
incubated with anti-a-amylase primary antibody (Sc-46657,
Santa Cruz Biotechnology; 1:200 dilution). A solution consist-
ing in 5% non-fat dry milk in TBS-Tween 20 was used for
blocking, for 2 h, with agitation at room temperature followed
by incubation with primary antibody overnight at 4 8C.
Salivary amylase bands were detected with an alkaline
phosphatase -linked secondary antibody against mouse IgG
(anti-mouse, GE Healthcare, 1:10,000 dilution) using a chemi-
fluorescent substrate (ECL Plus Western Blotting DetectionReagents, GE, Healthcare). Membranes were revealed using a
transiluminator (Bio-Rad Gel-doc system) and a semi-quanti-
tative analysis of salivary amylase expression was carried out
by using Quantity One software (BioRad).
2.6. Salivary a-amylase enzymatic activity
Dinitrosalicylic acid assay19 was used for measuring the
starch-hydrolyzing activity of salivary a-amylase. The reac-
tion mixture consisted 100 mL of 1% starch solution, 100 mL of
20 mM phosphate buffer (pH 7.0) and 50 mL saliva (diluted to a
protein concentration in enzymatic assay of 1.5–2.5 mg/ml in
the same phosphate buffer). After incubation at 37 8C for
20 min, in a thermostable water bath constant stirring, the
reaction was stopped by the addition of 100 mL DNS reagent
(1% dinitrosalicylic acid, 0.2% phenol, 0.05% sodium sulfite, 1%
sodium hydroxide). Samples were then placed in a boiling
water bath for 5 min, and subsequently cooled down to room
temperature. Further, 200 mL of sodium and potassium
tartrate (40%) and 900 mL of bidistilled water were added to
samples. Absorbance was measured using a spectrophotome-
ter (Hitachi U200) at 540 nm against a blank prepared using the
identical method, except the enzyme solution, which was
added to the mixture after the addition of the DNS solution.
The absorbance values were then converted to glucose
equivalent using a standard curve (0.2–2.0 mg/mL). The results
were expressed as mmol glucose/min/mg protein and as a
percentage of control (group receiving standard diet) consid-
ered as 100%.
2.7. Statistical analysis
Considering the objectives of the study, different statistical
approaches were carried out. After the end of experiment, the
measured and calculated variables were analyzed with
descriptive statistics. Subsequent analysis was carried out
using a median analysis and establishing a ranking according
to the percentile distribution of the variables: weight at the
end of the trial, weight gain throughout the test and weight
gain relative to the initial weight. The animals from sunflower
oil treatment were divided into two subgroups based on the
results of the previous analysis. The normality and homosce-
dasticity were tested respectively by Kolmogorov–Smirnov
and Levene methodologies. Variables such as body weight,
total food consumption and total energy consumption were
tested according ANCOVA, with the initial body weight as a
covariant. Serum biochemical parameters were tested accord-
ing ANOVA-GLM. When significant differences were found,
post hoc pooling was performed by Tukey’s method. Pearson
correlations between different variables were carried out,
taking into account the level of significance and the value of R.
All statistical analyses were performed by SPSS 20 software.
3. Results
3.1. Body weight and food intake
At the end of acclimation time (week 0), animals were
randomly assigned to two experimental groups [control
Fig. 1 – Initial body weights (A) and growth rate (B) of control (Cont; N = 6) and treatment (HFD; N = 13) groups. OR = obese
resistant (N = 7); OP = obese prone (N = 6). Week S3 represents the time at which the animals were allocated to individual
cages for acclimation, whereas week 0 represents the start of high-fat diet administration to randomly selected animals.
Data are presented as means W SEM. (*significant for P < 0.05) (ANCOVA analysis using the initial body weight as a
covariant).
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treatment for 18 weeks. At this time mean body weights from
control and from the group treated with the high fat diet did
not present significant differences (Fig. 1A).
After the 18 weeks all animals, including controls, had
gained weight. However, at this time, for the animals from the
high-fat dietary group, there was a large dispersion in the
values, suggesting the existence of animals with different
propensity to weight gain. The ratio between the weight gain
and initial body weight was used to allocate animals from
high-fat dietary group in two subgroups. Since quite different
ratios were observed, medians were used to create more
homogeneous groups according to the respective percentiles.
Analysis of variance was one ANCOVA to correct the possible
effect of the different initial body weights. The two distinct
subgroups, from the high-fat treatment group were constitut-
ed by: (i) individuals whose body weight gains and final bodyTable 1 – Body weight and food consumption.
Control 
Body weight (week 3) (g) 127.5  11.0 
Body weight (week 0) (g) 182.1  9.5a
Final body weight (g) 268.7  4.0a
Total food consumption (kg) 2.60  0.06a
Total energy consumption (Kcal)# 8.07  0.19a
OR = obese resistant; OP = obese prone. Values are means  SEM.
a,bFor each parameter, different letters represent significant differences a
analysis with the initial body weight as covariant and P < 0.05.
# Calculated values according to the energy content after nutritional an
chow diet).weights remain similar to control group (obese resistant, OR;
N = 7); (ii) individuals for which body weight gains and final
body weights were at least 10% higher than in control group
(obese prone, OP; N = 6) (Fig. 1 and Table 1), according to the
criteria reported by others.20 One rat from the high-fat diet
treatment group was excluded from the analysis because it
was identified as outlier. This was due to its abnormal weight
gain relatively to its final body weight, as evidenced by the
statistical analysis (abnormal value in the box-plot after using
the Z-score procedure afterwards confirmed by the Dixon
test).
Food intake differed among the groups. The animals
maintained on the high-fat diet ingested a lower amount of
food compared to controls (2.60  0.06 kg control vs
2.38  0.08 kg for OP and 2.12  0.039 kg for OR groups
treatment; values for the total amount consumed in the 18
weeks of experiment). Considering total energy consumption,OP OR
156.8  6.0 133.4  8.6
211.5  4.4a 187.1  9.2a
314.2  5.0b 267.3  8.4a
2.38  0.08b 2.12  0.04b
9.06  0.30b 8.06  0.15a
mong means. Mean comparisons were performed using the ANCOVA
alysis (3.8 kcal/g for the high fat diet and 3.1 kcal/g for the standard
Table 2 – Serum biochemical parameters measured after 18 weeks of a high fat or control diet.
Control OP OR Ref values#
Insulin (ng/mL) 0.75  0.02a 0.75  0.07a 0.85  0.05a 0.60–0.9021,22
Leptin (ng/mL) 1.69  0.17a,b 2.39  0.41b 1.34  0.17a 1.37–2.2923
TG (mg/dL) 79.1  6.8a 61.0  7.3a 45.3  2.8b 40.0–230.024,25
Total cholesterol (mg/dL) 127.0  9.4a 129.6  7.4a 119.3  8.8a 70.0–125.025
HDL (mg/dL) 60.3  3.6a 52.7  2.5a 43.5  5.2b 38.0–63.04
Total cholesterol/HDL 2.12  0.14a 2.48  0.14a 2.86  0.27b
OR = obese resistant; OP = obese prone. Data are presented as mean  SEM.
# Normal mean values for female Wistar adult rats.
a,bFor each parameter, different letters represent significant differences among means. Mean comparisons were performed using ANOVA
analysis for P < 0.05.
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subgroup compared to both the control and OR subgroups
(Table 1).
3.2. Blood biochemical parameters
All animals presented normal oral glucose tolerance tests both
at the beginning and at the end of the experiment. In both
times the mean glycaemic levels, from all the groups, ranged
from 68 to 90 mg/dL glucose following overnight fast,
increased to 100–115 mg/dL 30 min after the administration
of the oral bolus of glucose and returned to fasting values at
60 min (results not shown), indicating that no significant
differences in glucose tolerance were induced by the sunflow-
er oil enriched diet. Accordingly, fasting plasmatic insulin
levels, at the end of the dietary treatment, were similar among
the groups (Table 2). Concerning fasting plasmatic leptin
levels, differences were observed, with OP subgroup present-
ing values almost twice higher than the OR subgroup (Table 2).
Being leptin a hormone that promotes satiety, the relation
between leptin plasmatic levels and energy consumption was
investigated. A strong positive correlation was observed for
the animals fed the high fat diet (r = 0.71; P = 0.003), i.e., higher
plasmatic leptin levels were associated with higher energy
consumption (Fig. 2B), indicating higher ingestion.
The consumption of the sunflower oil enriched diet
induced differential changes in lipid profiles among OR and
OP subgroups. A 40% decrease in the plasmatic levels ofFig. 2 – Correlation between plasmatic leptin levels and
total energy consumption.triglycerides was observed in OR subgroup while OP presented
values similar to the ones from controls. Concerning total
cholesterol no differences were observed between the groups.
However, high-density lipoprotein (HDL) cholesterol was
approximately 30% lower in the OR subgroup and, accordingly,
total cholesterol to HDL ratio was significantly increased in
this subgroup (Table 2).
3.3. Salivary a-amylase expression levels and enzymatic
activity
The main aim of the present experiment was to study salivary
a-amylase secretion in individuals with different susceptibili-
ties to obesity. Differences in this salivary protein expression
levels and enzymatic activity were observed among the
experimental groups. Before the beginning of dietary treat-
ment, where all animals were fed standard rodent diet, OP
subgroup presented higher expression levels of a-amylase
when compared to both the control and OR groups, being these
last two groups similar (Fig. 3A).
After the chronic consumption of sunflower oil enriched
diet, OR subgroup presented an increased expression of
salivary a-amylase comparatively to the other experimental
groups (Fig. 3B). It is noteworthy that when compared to the
expression levels prior to the treatment, a-amylase expression
was significantly increased in the OR subgroup, whereas it was
maintained in the control and OP subgroup (Fig. 3B).
In concordance with protein expression, the salivary a-
amylase enzymatic activity from whole saliva collected at
the beginning of the trial (when animals were all maintained
on a standard rodent chow diet) was 1.6 fold higher in OP
individuals (Fig. 4).
At this time point, a-amylase enzymatic activity was
strongly correlated with future individual body weight gains
(r = 0.70; P = 0.032), i.e., individuals which gained more weight
during the 18 weeks high fat diet treatment presented higher
salivary a-amylase activities (Fig. 5A). Interestingly, this
relation (Pearson correlation coefficient) is even higher
considering only the animals that fed the high fat diet
(r = 0.76; P = 0.042) (Fig. 5B).
In the contrary, at the end of the dietary treatment the a-
amylase activity in OP subgroup was similar to the controls
while in the OR subgroup a-amylase activity was 3-fold
higher. Notice that, compared to the beginning of the trial,
salivary a-amylase enzymatic activity in OR subgroup was
increased 3 times (Fig. 4).
Fig. 3 – Representative Western blot analysis of a-amylase
in mixed saliva samples from control (C), obese-prone (OP)
and obese resistant (OR) animals. A: before dietary
treatment; B: after 18 weeks dietary treatment; Lower
panels show a-amylase expression quantified by
densitometric analysis of this protein immunoreactive
band. Data are presented as mean W SEM. (*differences
between high fat diet subgroups and control are
significant for P < 0.05).
Fig. 4 – Salivary amylase activity of mixed saliva samples
before and after dietary treatment. OP = obese prone;
OR = obese resistant. Data are presented as mean W SEM.
P < 0.05.
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The existence of individuals with propensity and individuals
with resistance to weight gain has been referred for both
animals and humans. In Wistar rats this differential response
in body weight changes has been already referred for
individuals submitted to high saturated fat diets26,27 and
has been attributed to different causes such as overconsump-
tion, due to these diets high palatability, or to the modulation
of gene expression linked to lipogenesis.28 Studies are not
consensual in terms of the potential of diets rich in
polyunsaturated fat for obesity development. Some authors
refer similar29 and others lower30 body weight gains, induced
by PUFA comparatively to the ones induced by saturated fat.Fig. 5 – Correlation between body weight gains and a-amylase 
dietary treatment. (A) All groups; (B) OR and OP groups.In the present study, a differential individual response in
the rate of weight gain was observed for rats consuming a
high-fat-enriched with sunflower oil diet. Despite being an
unsaturated fat, the sunflower oil used in this study contains a
considerable amount of n-6 PUFA over n-3 PUFA, the opposite
of other oils such as olive or rapeseed oils,3 and a key factor in
high-fat induced obesity.31 Our results support the fact that a
high-fat diet rich in n-6 PUFA induce weight gain and
eventually obesity in animals with genetic susceptibility,
such as the OP subgroup.
Despite obesity development in susceptible animals, the
effects of the tested diet appeared not to be as deleterious as
the ones produced by saturated fat. High amounts of saturated
dietary fats lead to insulin resistance in rats32 what canenzymatic activity from saliva collected before high-fat
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the present study, no changes in oral glucose tolerance tests or
fasting insulinemia were observed as a consequence of the
consumption of this high fat diet consumption for 18 weeks.
The fatty acid composition may be a possible explanation for
these results, since sunflower oil is rich in polyunsaturated fat,
therefore not inducing insulin resistance, as suggested by
others.33
Accordingly with fasting leptin levels, it is possible to
hypothesize that the weight gain observed in some of the
animals (OP animals) can be the result of a degree of leptin
resistance by these. Leptin is mainly produced by adipose
tissue and is highly involved in the control of ingestion by
inducing satiety. Despite the increased levels of plasmatic
leptin in OP animals, higher energy intake was observed in this
subgroup suggesting a reduced response to this hormone and
a consequent lack of the fall in satiety, a factor already pointed
out as responsible for diet induced obesity.34
Lipid profiles were accessed with the aim of adding
information on the metabolic effects of the fat used. These
effects were observed to be dependent on the propensity for
obesity. In OR subgroup the dietary treatment induced a
decrease in triacylglycerol and HDL levels. The maintenance of
total cholesterol resulted in an increase of total cholesterol/
HDL ratio in this subgroup. Similar results were reported by
other authors for sunflower oil enriched diets, for both
triacylglycerol levels35 and total cholesterol/HDL ratio.36
Cholesterol is precursor of corticosteroids and androgens,
which increased levels are ultimately related to insulin
resistance.37,38 Although insulinemias and glucose tolerance
curves were similar to the ones from control individuals, as
discussed above, the hypothesis of OR individuals became less
sensitive to insulin and/or present metabolic changes, if
maintained for a longer period in a high fat diet, is not to
discard. By the contrary, lipid profiles from OP individuals did
not differ from control animals. Besides concluding that the
polyunsaturated high fat diet did not induce severe dyslipi-
daemias in either OP or OR subgroups, for the period
considered in this study, it is worthwhile to note that the
effects of polyunsaturated fat are complex and should not be
generalized, but instead should have into consideration the
metabolic characteristics of each individual, where the genetic
background is certainly playing a central role.
In the present study differences in the expression and
enzymatic activity of salivary a-amylase, both before and after
the high fat diet trial were observed among the groups. The a-
amylase levels measured before animals entered the trial was
higher in individuals which were further allocated to OP
subgroup and were strongly correlated with the rate of body
weight gain achieved during the experiment. Consequently,
the levels of this protein seem to behave as a predictor of the
susceptibility individuals have to become obese. The major
role of this salivary protein in the oral cavity is to hydrolyse
starch to maltose and maltotriose. It has been stated that
considerable starch hydrolysis occurs in the oral cavity39 and
can continue after swallowing, due to the presence of partially
digested starch, which appears to protect salivary a-amylase
from acid inactivation.40 Therefore, higher levels of this
salivary enzyme could lead to a higher efficiency in starch
digestion, what can be hypothesized to increase carbohydrateabsorption, contributing to the greater increase in body weight
observed in OP animals.
Salivary a-amylase has been proposed as a marker of
sympathetic nervous system activity.12 Stimulation of beta-
adrenergic receptors results in increases in salivary total
protein and a-amylase output.14 Based on that, we can assume
that OP animals presented a higher activity of this branch of
autonomic nervous system, at an early age. Sympathetic
nervous system activity is related to energy homeostasis,
increasing energy expenditure by stimulating adrenergic
thermogenesis, which in turn results in expending energy
as heat.41 However, a chronic sympathetic stimulation has
been suggested to result in desensitization of the beta-
adrenergic signalling pathway, which has been considered a
possible explanation for weight gain increases with age.42
Moreover, from our observations, at the end of the 18 weeks
experiment OP animals did not present a-amylase levels
augmented, even presenting higher body weights and higher
plasmatic leptin levels. This also goes in accordance with the
beta-adrenergic desensitization hypothesis.
Also, it was observed that while the OR animals adjusted
food intake to fulfil their caloric needs the OP animals did not.
Indeed the OP subgroup presented a significantly higher
caloric intake compared to both OR and control subgroups,
hence contributing to their augmented weight gain. The
reasons for food consumption above their needs in the OP
subgroup are unknown but an increased palatability, widely
reported as a drive to consumption43 due to the higher salivary
a-amylase levels might be one contributing factor.
Another important finding was that a-amylase secretion is
3-fold increased after 18 weeks consuming the high fat diet in
the subgroup resistant to weight gain. Since OR animals
consumed lower amounts of starch than the other individuals,
the increase in a-amylase secretion might be an adaptive
response mechanism to increase digestive efficiency. More-
over, sympathetic nervous system activity increases with the
consumption of high fat diet17 and, in the same line of thought
described above, since OR animals continues to be sensible to
adrenergic stimulation, it is not surprising a rise in a-amylase
secretion.
Nonetheless, the use of salivary a-amylase as marker of
sympathetic activity has some limitations44 and further
studies are important to elucidate the meaning of increases
in this salivary protein expression induced by high fat diets
only in animals resistant to weight gain.
Finally, from our knowledge, although saliva has been
extensively explored as a source of biomarkers for diverse
pathological conditions, there is a lack of studies comparing
salivary protein composition according to individual propen-
sity for obesity. Our results suggest that salivary a-amylase
secretion differ between individuals with and without
propensity to weight gain and that it may be meaningful in
increasing understanding about obesity development. More-
over, a recent study demonstrated that salivary amylase gene
(AMY1) copy number variations predisposes to obesity.45
Although, no salivary protein expression was accessed in this
study, it emphasises the importance of this salivary protein
related to weight gain and BMI. Further studies elucidating the
mechanisms which result in this observed higher secretion of
this protein, and studies searching for the potential changes of
a r c h i v e s o f o r a l b i o l o g y 6 0 ( 2 0 1 5 ) 8 5 4 – 8 6 2 861other salivary proteins in a pre-obesity state, can ultimately
allow early dietary and behavioural interventions, avoiding
the pathological state.
5. Conclusion
In summary, chronic consumption of high amount of
sunflower oil differentially induced obesity in rats, according
to individual propensity, without producing the negative
effects usually attributed to saturated fat, namely insulin
resistance and/or dyslipidaemia. It is concluded that saliva
may be useful to evaluate susceptibility for obesity. Salivary a-
amylase levels in young animals are related to the rate of
future weight gain. Although the mechanisms responsible for
the differential expression of salivary a-amylase according to
obesity susceptibility need to be explored, the obtained results
show that saliva composition relates to the amount of weight
gain. Moreover, the consumption for several weeks of a high
fat diet evoked an increase in salivary a-amylase levels in
individuals resistant to obesity, possibly as an adaptation to
optimize the usage of a poorer starch diet. Taking together
these results reinforce the notion that salivary a-amylase
levels are dependent on diet characteristics and emphasize
the potential of saliva in studies about susceptibility for weight
gain and obesity development.
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